ArticleRheumatology and therapy2023

PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis.

Stefan Siebert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.